Diagnostic Value of Endoscopic Ultrasound Elastography and Contrast Enhanced Endoscopic Ultrasound for Differential Diagnosis of Gallbladder Polyp

February 28, 2022 updated by: Sang Hyub Lee, Seoul National University Hospital

Gallbladder polyps are often detected incidentally by ultrasonography. The most of gallbladder polyps are non-neoplastic such as cholesterol polyps and do not need further treatments. However, neoplastic polyps, which need additional treatments to prevent malignancy, show the same appearance on ultrasound. Clinically, the differential diagnosis between cholesterol polyps and adenomatous polyps is very important for patient follow-up and treatment. However, differential diagnosis between these two conditions is difficult using conventional trans-abdominal ultrasound.

Endoscopic ultrasound (EUS) is less affected and disturbed by subcutaneous fat or intraabdominal air, so a clearer image of pancreatobiliary system can be obtained. In addition, EUS elastography and contrast enhanced EUS are recently introduced. EUS elastography enables practitioners to evaluate the stiffness of a target lesion and compare it with surrounding tissues (strain ratio). Also, contrast enhanced EUS is used widely with additional information such as presence of vessels and enhancement pattern of soft tissues. Several studies have been published that EUS elastography can help in the differential diagnosis of pancreatic solid lesions.

Although studies have been conducted to confirm the usefulness of transabdomnial ultrasound with elastography or contrast enhancement at differentiating gallbladder polyps, no prospective studies have been conducted to evaluate the usefulness of EUS elastography or contrast enhanced EUS for gallbladder polyp. Therefore, with this prospective study, we would like to evaluate the diagnostic value of EUS elastography and contrast enhanced EUS for differential diagnosis of gallbladder polyps.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Sang Hyub Lee, MD., PhD.
  • Phone Number: +082 2-2072-4892
  • Email: gidoctor@snuh.org

Study Locations

      • Seoul, Korea, Republic of, 101
        • Recruiting
        • Seoul National University Hospital
        • Principal Investigator:
          • Sang Hyub Lee, MD PhD
        • Contact:
          • Sang Hyub Lee, MD PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients who have GB polyps and are recommended cholecystectomy due to large size of polyp (8-10 mm or larger).

Description

  1. Inclusion Criteria:

    1. Gallbladder polyp of 8-10mm or more in size confirmed by imaging tests
    2. Must be 19 years old or older
    3. With voluntary agreement to participate in the study after be informed about the necessity of EUS due to the clinical necessity
  2. Exclusion Criteria:

    1. Unable to confirm histological diagnosis (ex. Patients did not underwent cholecystectomy)
    2. Younger than 18 year-old
    3. Without agreement with this study or informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pathologic diagnosis of gallbladder polyp after cholecystectomy
Time Frame: within 10 days after operation
Pathologic diagnosis of gallbladder polyps or masses in cholecystectomy specimen
within 10 days after operation
Difference of strain ratio
Time Frame: Within two years of starting the study
Differences in strain ratio between non-neoplastic and neoplastic gallbladder polyps.
Within two years of starting the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Optimal cut-off valve of strain ratio
Time Frame: Within two years of starting the study
Optimal cut-off valve of strain ratio for differential diagnosis between cholesterol polyps and adenomatous polyps
Within two years of starting the study
Diagnostic value of EUS-elastography
Time Frame: Within two years of starting the study
Sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of EUS-elastography for diagnosis of cholesterol polyps.
Within two years of starting the study
Diagnostic value of contrast enhanced EUS
Time Frame: Within two years of starting the study
Sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of contrast enhanced EUS for diagnosis of cholesterol polyps.
Within two years of starting the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2020

Primary Completion (Anticipated)

April 1, 2022

Study Completion (Anticipated)

June 1, 2022

Study Registration Dates

First Submitted

June 2, 2020

First Submitted That Met QC Criteria

June 2, 2020

First Posted (Actual)

June 4, 2020

Study Record Updates

Last Update Posted (Actual)

March 15, 2022

Last Update Submitted That Met QC Criteria

February 28, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

3
Subscribe